EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars

Sarfaraz K Niazi iD, Sesselja Omarsdottir

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179240 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sarfaraz K Niazi und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Illinois, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals, Lectins, Polysaccharides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycan profile comparisons are one of the most tedious analytical exercises for establishing compliance with recombinant therapeutic protein batches. Based on its intensive research, the FDA has confirmed that lectin array binding with fluorescent monitoring is the fastest and most reliable method for profile comparisons. Using a database of over 150 biological products expressed in nine diverse mammalian cell systems, the FDA immobilized 74 lectins to study their binding using fluorescently labeled glycoproteins. The FDA identified nine distinct lectins from a custom-designed lectin microarray: rPhoSL, rOTH3, RCA120, rMan2, MAL_I, rPSL1a, PHAE, rMOA, and PHALs, which detect core fucose, terminal GlcNAc, terminal β-galactose, high mannose, α-2,3-linked sialic acids, α-2,6-linked sialic acids, bisecting GlcNAc, terminal α-galactose, and triantennary structures, respectively. This method can be used for screening and routine testing and to monitor batch-to-batch variability of therapeutic proteins, including establishing analytical similarity as a crucial part of biosimilar development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosimilar PharmaceuticalsLectinsPolysaccharidesAnimalsHumansDrug ApprovalFluorescenceGlycoproteinsUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

FDAantibodiesbiosimilarsfluorescent monitoringlectinsmicroarray

Substanzen

Biosimilar PharmaceuticalsGlycoproteinsLectinsPolysaccharides

Autor:innen und Institutionen

  • College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.
  • Faculty of Pharmaceutical Sciences, University of Iceland, IS-107 Reykjavik, Iceland.

ORCID-Profile: Sarfaraz K Niazi

Zitieren

APA

Niazi, S. K., & Omarsdottir, S. (2024). Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179240

Vancouver

Niazi SK, Omarsdottir S. Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179240

BibTeX
@article{Niazi2024,
  author = {Niazi, Sarfaraz K and Omarsdottir, Sesselja},
  title = {Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179240}
}
Kostenlos starten →